Binding Site’s IMMUNOLOGICALS GROUP introduces highly purified Borrelia and Chikungunya Glycoprotein antigens for use in both in-vitro diagnostic manufacturing and research applications
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature